6 results
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... candidiasis) • Euglycemic ... diabetic ketoacidosis ... Summary #DM2 #diabetes ... #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Ketoacidosis (EuDKA ... ) SGLT2 Inhibitors ... #EuDKA #diagnosis ... #management #endocrinology
Ketosis Disorders - Comparison Table
 • Starvation Ketosis
 • Alcoholic Ketoacidosis (AKA)
 • Diabetic Ketoacidosis (DKA)
• Alcoholic Ketoacidosis ... ) • Diabetic Ketoacidosis ... (DKA) • Euglycemic ... #differential #diagnosis ... #management #endocrinology
Ketosis Disorders
Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
• Alcoholic ketoacidosis ... • Euglycemic ... seen with SGLT inhibitors ... #differential #diagnosis ... #management #endocrinology
Hyperglycemic Crisis - Algorithm for DKA/HHS

Diagnostic criteria for DKA:
 • pH < 7.3
 • Anion gap
for DKA/HHS Diagnostic ... Crisis #Algorithm #management ... #endocrinology ... #Diabetes #DM2 # ... Ketoacidosis
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... Stimulates Insulin, Inhibits ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology